Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Colorcon
Healthtrust
Julphar
Fuji
AstraZeneca
US Army
Merck
Cipla
Accenture
QuintilesIMS

Generated: August 18, 2017

DrugPatentWatch Database Preview

DOXAZOSIN MESYLATE Drug Profile

« Back to Dashboard

What is the patent landscape for Doxazosin Mesylate, and when can generic versions of Doxazosin Mesylate launch?

Doxazosin Mesylate is a drug marketed by Mylan, Nesher Pharms, Zydus Pharms Usa Inc, Accord Hlthcare, Watson Labs Inc, Idt Australia Ltd, Teva, Sandoz, Pliva, Ivax Sub Teva Pharms, Dava Pharms Inc, Genpharm, Actavis Elizabeth, and Apotex. and is included in fifteen NDAs.

The generic ingredient in DOXAZOSIN MESYLATE is doxazosin mesylate. There are thirteen drug master file entries for this compound. Thirty-four suppliers are listed for this compound. Additional details are available on the doxazosin mesylate profile page.

Summary for Tradename: DOXAZOSIN MESYLATE

Patents:0
Applicants:14
NDAs:15
Suppliers / Packagers: see list32
Bulk Api Vendors: see list59
Clinical Trials: see list558
Patent Applications: see list1,377
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:DOXAZOSIN MESYLATE at DailyMed

Pharmacology for Tradename: DOXAZOSIN MESYLATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Teva
DOXAZOSIN MESYLATE
doxazosin mesylate
TABLET;ORAL075353-001Jan 12, 2001DISCNNoNo► Subscribe► Subscribe► Subscribe
Sandoz
DOXAZOSIN MESYLATE
doxazosin mesylate
TABLET;ORAL075646-004Oct 18, 2000DISCNNoNo► Subscribe► Subscribe► Subscribe
Genpharm
DOXAZOSIN MESYLATE
doxazosin mesylate
TABLET;ORAL075466-001Oct 18, 2000DISCNNoNo► Subscribe► Subscribe► Subscribe
Apotex
DOXAZOSIN MESYLATE
doxazosin mesylate
TABLET;ORAL075580-004Oct 18, 2000ABRXNoNo► Subscribe► Subscribe► Subscribe
Dava Pharms Inc
DOXAZOSIN MESYLATE
doxazosin mesylate
TABLET;ORAL076161-001Jun 10, 2004ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Healthtrust
Merck
Daiichi Sankyo
Baxter
Federal Trade Commission
Medtronic
Boehringer Ingelheim
Accenture
Farmers Insurance
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot